Females of African American Legacy Empowering Self (FemAALES) (FemAALES)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02189876 |
Recruitment Status :
Completed
First Posted : July 15, 2014
Last Update Posted : August 3, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
HIV | Behavioral: Standard of Care Behavioral: FemAALES | Not Applicable |
Two thirds of female HIV/AIDS cases occur in Black women and an estimated 76% of these are attributed to heterosexual contact. HIV is the third-leading killer of Black women ages 25-44, and STI associated morbidity may contribute to racial disparities in cervical cancer, adverse pregnancy outcomes, and infant mortality.
The investigators propose to test the efficacy of the FemAALES of African American Legacy Empowering Self Intervention in a population of adult Black/African American women who have either no health insurance or a public/subsidized form of health insurance against a Control or "Standard of Care" arm involving family planning and STI counseling.
In addition, the investigators will explore the impact of the FemAALES intervention on the use of new media for social support and networking, obtaining health information, and identifying resources and services. FemAALES incorporates cultural contextual, and partnership issues and promotes access to resources not readily available to this population. FemAALES curriculum is guided by the Theory of Reasoned Action and Planning and Critical Thinking and Cultural Affirmation Model developed by a collaborating community-based organization.
The primary specific aims are to:
-
Determine the impact of the FemAALES of African American Legacy Empowering Self (FemAALES II) on HIV risk factors including:
- number of sex partners
- unprotected anal/vaginal sex
- incidence of bacterial STIs
-
Determine the impact of the FemAALES interventions on psychosocial outcomes, including self-efficacy for safer sex negotiation and discussions with partners regarding HIV/STI testing and risk
- Hypothesis 1: Compared to the control, FemAALES will reduce the number of vaginal/anal sex partners and number of episodes of unprotected intercourse at 3months and 9 months post intervention
- Hypothesis 2: Compared to the control, FemAALES will reduce the incidence of gonorrhea and chlamydia
- Hypothesis 3: Compared to the control, FemAALES will improve self-efficacy for condom negotiation
- Hypothesis 4: Compared to the control. FemAALES will increase the proportion of women who have discussions regarding sexual and drug use risk factors with their sexual partners.
A third, exploratory aim, is to assess the impact of the FemAALES intervention on the use of new social media for social support and networking, obtaining health information and identifying resources and services.
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 256 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Prevention |
Official Title: | Reducing HIV/STD Risk in African American Women With At-Risk Male Partners |
Actual Study Start Date : | July 2013 |
Actual Primary Completion Date : | April 2018 |
Actual Study Completion Date : | April 2018 |

Arm | Intervention/treatment |
---|---|
Experimental: FemAALES
Females of African American Legacy Empowering Self Intervention. A nine session, theoretically grounded small group intervention.
|
Behavioral: Standard of Care
All participants will be provided a STD/HIV pre-test counseling session. This session will be provided by either certified project staff or clinical staff at a Los Angeles clinic that conduct State of CA Fam Pact services for patients who are of child bearing age, including our current study partner St. John's Well Child and Family Center and our former study partner, JWCH (John Wesley Community Health) Institute-Wesley Health Center Clinics. Following the counseling session, the participant will be asked to provide a sample of urine to test for Chlamydia and Gonorrhea. Behavioral: FemAALES Women will attend 9 small group sessions over 4 weeks. Three of these sessions will focus specifically on participants learning to use a computer, set up an email account, communicate with the team and the group using the Internet, and developing a prevention message for display on project website and social media accounts. The other 6 sessions will include discussions on the following topics: being a Black woman in American, Black history, assessing personal health, changing current behaviors, HIV/AIDS information, and education, self-empowerment, communication skills, reasons to change, and goal setting. |
Active Comparator: Standard of Care
A one-time STD/family planning testing and counseling session provided to all study participants.
|
Behavioral: Standard of Care
All participants will be provided a STD/HIV pre-test counseling session. This session will be provided by either certified project staff or clinical staff at a Los Angeles clinic that conduct State of CA Fam Pact services for patients who are of child bearing age, including our current study partner St. John's Well Child and Family Center and our former study partner, JWCH (John Wesley Community Health) Institute-Wesley Health Center Clinics. Following the counseling session, the participant will be asked to provide a sample of urine to test for Chlamydia and Gonorrhea. |
- Change in number of sex partners from baseline [ Time Frame: 3 and 9 months ]Determine the impact of the FemAALES intervention compared to the control condition on the number of vaginal and anal sex partners in the prior 90 days .
- Change in frequency of unprotected sex from baseline. [ Time Frame: 3 and 9 months ]Determine the impact of the FemAALES interventions compared to the control condition on the number of vaginal or anal sex acts reported without condoms in the prior 90 days.
- Change in bacterial STDs from baseline [ Time Frame: 9 months ]Examine the impact of the FemAALES interventions compared to the control condition on the incidence of gonorrhea and chlamydia.
- Change in Safer Sex Negotiation Skills and Behaviors [ Time Frame: 3 and 9 months ]Determine the impact of the FemAALES conditions compared to the control condition on psychosocial outcomes, including self-efficacy for safer sex negotiation and discussions regarding HIV/STI risk with sexual partners.
- Intervention Effect on Use of New Media [ Time Frame: 9 months ]Determine the impact of the FemAALES intervention on the frequency and types of use of new media for social support, health information, and identifying resources.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 54 Years (Adult) |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- female sex
- self-identifies as Black/African American
- 18 years of age or older
- English speaking
- has had unprotected vaginal or anal sex in the last 90 days
- any male partner in the last 90 days has done one or more of the following: had sex with a man; had sex with a male-to-female transgender; used crack cocaine, heroin, or methamphetamines; been incarcerated for more than 6 months; had sex with other female partners during the relationship; OR - a male partner in the last 90 days has an unknown sexual history
- publicly funded or public subsidized health insurance
Exclusion Criteria:
- participated in a small group HIV prevention program in the past 12 months, participated in HARRP program in the past 12 months, has private insurance, refuses chlamydia or gonorrhea test at baseline,

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02189876
United States, California | |
St. John's Well Child and Family Center | |
Los Angeles, California, United States, 90037 | |
Charles Drew University of Medicine and Science | |
Los Angeles, California, United States, 90059 |
Principal Investigator: | Nina T Harawa, Ph.D, MPH | Charles Drew University | |
Principal Investigator: | Martin Shapiro, MD Ph.D MPH | University of California, Los Angeles | |
Principal Investigator: | Samuel Gonzalez, MS | St. John's Well Child and Family Center |
Responsible Party: | Charles Drew University of Medicine and Science |
ClinicalTrials.gov Identifier: | NCT02189876 |
Other Study ID Numbers: |
MD-13-010 P20MD000182 ( U.S. NIH Grant/Contract ) |
First Posted: | July 15, 2014 Key Record Dates |
Last Update Posted: | August 3, 2018 |
Last Verified: | August 2018 |
HIV Prevention Behavioral Intervention Condom Use African American |
Sexually Transmitted Disease Sexually Transmitted Infection Internet |